Product News

Share this article:

Forest Laboratories and Cypress Bioscience launched Savella, a selective serotonin and norepinephrine dual reuptake inhibitor, for fibromyalgia. The product will be available in drug stores April 28.

 

Sanofi-Aventis launched Apidra SoloSTAR, an insulin pen, indicated for adults and children 4 years and older, with type 1 diabetes or adults with type 2 diabetes.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions